New Jersey Assembly Bill A3093

New Jersey 2026-2027 Regular Session

• Introduced: 1/13/26
• Refer: 1/13/26

Caption

Requires hospitals to provide breast cancer patients with information concerning reconstructive surgery; prohibits certain provisions in managed care plan contracts.

Impact

The bill aims to empower breast cancer patients by ensuring they are aware of and can access reconstructive surgery options tailored to their individual needs. This will enhance patient autonomy in making healthcare decisions regarding their treatment and aftercare. Additionally, the legislation states that managed care contracts will not include provisions that may restrict healthcare providers from recommending certain surgeons based on network affiliations, thus promoting comprehensive patient care without unnecessary limitations.

Summary

Assembly Bill A3093 requires general hospitals that provide surgical services for the treatment of breast cancer and related conditions to inform patients of their rights regarding reconstructive surgery. Specifically, hospitals must provide written notices to patients diagnosed with breast cancer outlining their right to consult with a board-certified plastic surgeon of their choosing for reconstructive options. This information must be given at the time of diagnosis and prior to any surgical procedures, emphasizing the importance of informed patient consent and options during treatment.

Contention

Notable points of contention may arise from the implications this bill has on managed care organizations and insurance providers. Proponents argue that it is essential for patient well-being and rights, while critics might express concerns over how these mandates could potentially affect care costs or network dynamics. Moreover, there could be apprehensions regarding the challenges healthcare providers may face in navigating this new requirement, especially in relation to existing contracts with insurance carriers.